Sana Biotechnology, Inc. (SANA)

NASDAQ: SANA · Real-Time Price · USD

2.370

+0.030 (1.28%)

At close: Nov 6, 2026, 4:00 PM EST

2.360

-0.010 (-0.42%)

After-hours: Nov 6, 2026, 7:49 PM EST

Sana Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	41.1	71.87	127.57	133.52	176.77	253.03
Short-Term Investments	80.62	66.51	24.93	71.68	247.2	297.97
Cash & Short-Term Investments	121.73	138.38	152.5	205.2	423.96	551
Cash Growth	-20.47%	-9.26%	-25.68%	-51.60%	-23.05%	45.66%
Prepaid Expenses	6.82	6.1	4.48	4.49	14.37	7.11
Restricted Cash	3.76	4.2	3.83	3.83	6.1	-
Total Current Assets	132.31	148.68	160.81	213.52	444.44	558.1
Property, Plant & Equipment	43.44	65.22	135.27	145.59	159.4	161.78
Long-Term Investments	-	-	-	-	10.05	195.88
Goodwill	140.63	140.63	140.63	140.63	140.63	140.63
Other Intangible Assets	59.2	59.2	59.2	59.2	59.2	59.2
Other Long-Term Assets	0.55	3.17	5.12	6.37	9.01	13.82
Total Assets	376.13	416.89	501.02	565.3	822.72	1,129

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.95	1.67	5.21	4.11	2.86	2.22
Accrued Expenses	18.97	21.52	27.69	37.98	39.12	28.91
Current Portion of Leases	13.32	15.34	12.53	13.2	12.39	9.16
Other Current Liabilities	40.65	40.2	-	9.2	57.14	58.95
Total Current Liabilities	74.88	78.73	45.43	64.49	111.5	99.24
Long-Term Leases	40.52	70.92	81.66	90.9	95.86	101.78
Other Long-Term Liabilities	80.36	106.36	123.42	122.41	116.04	199.89
Total Liabilities	195.76	256.01	250.52	277.79	323.41	400.91

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.03	0.03	0.02	0.02	0.02	0.02
Additional Paid-In Capital	2,120	2,010	1,855	1,626	1,558	1,515
Retained Earnings	-1,939	-1,849	-1,605	-1,338	-1,055	-785.36
Comprehensive Income & Other	-0.1	0.03	0.01	-0.06	-4.33	-1.37
Total Common Equity	180.36	160.88	250.5	287.51	499.32	728.5
Shareholders' Equity	180.36	160.88	250.5	287.51	499.32	728.5
Total Liabilities & Equity	376.13	416.89	501.02	565.3	822.72	1,129

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	53.84	86.26	94.2	104.1	108.25	110.94
Net Cash (Debt)	67.89	52.12	58.3	101.1	325.76	635.93
Net Cash Growth	7.22%	-10.60%	-42.33%	-68.97%	-48.77%	86.99%
Net Cash Per Share	0.23	0.21	0.25	0.52	1.73	3.82
Filing Date Shares Outstanding	299.63	266.87	225.02	220.45	191.35	185.18
Total Common Shares Outstanding	299.52	266.73	223.92	197.86	191.02	184.93
Working Capital	57.43	69.95	115.38	149.03	332.93	458.87
Book Value Per Share	0.60	0.60	1.12	1.45	2.61	3.94
Tangible Book Value	-19.46	-38.94	50.68	87.68	299.49	528.68
Tangible Book Value Per Share	-0.06	-0.15	0.23	0.44	1.57	2.86
Machinery	-	42.6	57.79	54.77	64.76	49
Construction In Progress	-	-	40.34	26.33	1.71	1.39
Leasehold Improvements	-	39.06	33.34	31.36	34.43	33.85

SEC Filings: 10-K · 10-Q